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Summary
Objective: This study was carried out to determine the prevalence of hepatitis B virus (HBV)
markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.
Materials and methods: A cross-sectional survey was done among male Saudi voluntary blood
donors at the blood bank of the King Khalid tertiary care hospital in the northwest region of Saudi
Arabia. A total of 3192 subjects were included in the study over the period from June 1, 2005 toMay
31, 2006. Subjects were tested for evidence of HBV infection plus other relevant blood-borne
pathogens. A questionnaire sheet for the collection of personal information (such as name, age, and
sex), socioeconomic data (such asmarital status, education, and occupation), family history of HBV
infection, history of immunization against HBV, and history of past exposure to a high risk procedure
orbehavior,waspreparedandusedforeachsubject.Dataweretabulatedandstatistically analyzed.
Results: Among the studied sample, the prevalence of HBsAg (hepatitis B surface antigen) was
found to be 3.0% and the prevalence of anti-HBc (anti-hepatitis B core antigen) was found to be
18.7%. Blood donors with positive HBV markers showed significant association with increased age,
being married, lower educational level, specific occupations such as blue collar worker and the
military, family history of HBV infection, and lack of immunization. However, there was no
significant association with history of exposure to high-risk procedure or behavior.
Conclusions: The prevalence of HBV infection among male Saudi blood donors in the northwest
region of Saudi Arabia is high compared to that reported from the central capital area (Riyadh).
Public health education programs on HBV infection, adult hepatitis B immunization programs, and
raising socioeconomic standards should be initiated in order to target the high-risk groups found in
this study. Furthermore, a community-based study is recommended to investigate HBV infection in
the northwest region of Saudi Arabia.
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Hepatitis B virus (HBV) infection is a major health problem in
many countries of the world, especially those in Asia, the
Middle East, and Africa.1 It is a major cause of chronic liver
diseases, particularly cirrhosis and hepatocellular carci-
noma. Although the incidence of HBV infection has markedly
reduced following mass HB vaccination programs, the aver-
age prevalence of chronic HBV infection worldwide is still
estimated at 6.6% (2.8% in developed countries and 7.6% in
developing countries).2 It was predicted that there would be
at least 400 million cases of HBV chronic infection worldwide
in the year 2000, and the figure has now risen beyond this
limit. HBV infection has an acute case fatality rate of 0.5—
1.0%, while 2—10% of cases end up in chronic infection after 5
years. Premature mortality from chronic liver disease occurs
in 15—25% of chronically infected persons, highlighting the
importance of this global health concern.3
In recent years, there has been increased public concern
regarding the safety of blood and blood products with respect
to transfusion-transmitted infections, mainly HBV, hepatitis
C virus (HCV), and human immunodeficiency virus (HIV).4 In
the Kingdom of Saudi Arabia, the average prevalence rate of
HBsAg (hepatitis B surface antigen) in the adult population in
1988 was approximately 8%, while 60% had evidence of past
exposure to HBV.5,6 Also, a high prevalence of HBV infection
among children was reported in 1992; approximately 7% of
apparently healthy children less than 10 years of age were
positive for HBsAg and 20% were positive for at least one of
the markers of HBV.7 The prevalence of HBsAg in healthy
blood donors ranges from 2.7% to 9.8%.6,8 However several
surveys of voluntary blood donors in the Kingdom of Saudi
Arabia have shown marked regional variations in the pre-
valence of HBV.9—12
In the region of Tabuk, which occupies the northwestern
part of Saudi Arabia, information on the epidemiology and
prevalence of HBV infection among the different population
groups is inadequate. Most of the previous studies in the
region have been limited to children less than 12 years of age
as part of national studies aiming at evaluating the efficacy of
HBV vaccine.
This study was carried out to determine the prevalence of
HBVmarkers among blood donors at a tertiary care hospital in
Tabuk, northwestern Saudi Arabia.
Methods
Tabuk is located in the northwest of Saudi Arabia. Its popula-
tion is approximately 700 000 people, and they are served by
10 hospitals including the 300-bed King Khalid tertiary care
hospital. The screening of blood donors is performed mainly
in the laboratory of the King Khalid hospital using centrally
procured kits and uniform protocols. The results of HBV
marker testing obtained during the screening of blood donors
are registered and reported. This research included all
screened healthy male Saudi voluntary blood donors at the
blood bank of King Khalid hospital over the period June 1,
2005 to May 31, 2006. They were volunteers and mainly
relatives and friends of patients. In Saudi Arabia, females
rarely donate blood due to cultural issues. Only three non-
Saudi females donated blood during the period of the study.Non-Saudi male and female blood donors were excluded from
the study as they are exposed to mandatory screening for
blood-borne pathogens before coming to Saudi Arabia to
work and prior to the granting and renewal of their residency
permits in this country.
Subjects were tested for HBsAg, anti-HBc (anti-hepatitis
B core antigen), and antibodies to HCVand HIV, in addition to
venereal disease research laboratory (VDRL) and malaria as
part of the routine screening for blood donation. From each
subject, 5—10 ml of venous blood was obtained and serum
was separated by centrifugation and then forwarded for
testing. A commercially available enzyme immunoassay
(EIA; Abbott Laboratories, Chicago, IL, USA) was used for
the detection of HBsAg and anti-HBc. In addition, a ques-
tionnaire sheet was prepared and used for each study sub-
ject. This was used to collect personal information (name
(optional), age, and sex), socioeconomic data (such as mar-
ital status, education, and occupation), history of exposure
to risky procedures or behaviors, family history of HBV
infection, and history of immunization against HBV in three
doses. Education was categorized as higher education for
university degree and lower education for no education,
primary, middle, or high school level only. Doctors, engi-
neers, teachers, lawyers, and accountants were considered
professionals while those in other occupations included
general laborers, military personnel, and students. Study
subjects were divided into four groups regarding exposure to
risky procedures or behaviors. Group 1 included subjects
with a history of surgery, blood transfusion, or dental sur-
gery. Group 2 included those exposed to traditional risk
procedures such as cauterization, scarification, or tattoo-
ing. Group 3 included those exposed to high-risk sexual
behavior such as unprotected sex, multiple sexual partners,
anal sex, or sexually transmitted diseases. Group 4 included
those involved in intravenous (IV) drug addiction, needle or
sharps injuries. A history of immunization was considered
‘yes’ if the subject had received three doses of HB vaccine at
0, 1, and 6months, while ‘no’was set for lesser or no doses or
unknown history. Data were obtained, tabulated, and sta-
tistically analyzed using EPI Info software (version 6.0,
Centers for Disease Control and Prevention, Atlanta, GA,
USA). Subjects with positive HBV markers were compared to
those with negative HBV markers with regard to different
risk factors. Odds ratios with 95% confidence intervals were
calculated. A p-value of less than 0.05 was considered
significant.
Results
A total of 3192 subjects were included in the study. The age
range was 18—52 years, the median age was 27 years, and the
mean age was 28.6  6.7 years. The prevalence of HBsAg was
found to be 3.0% and the prevalence of anti-HBc was found to
be 18.7%. The distribution of blood donors according to age,
marital status, education, occupation, exposure to risky
procedures/behavior, family history of HBV infection, and
history of HB immunization in relation to HBV markers is
shown in Table 1.
Regarding age, HBV markers were significantly higher in
age groups 30—39 years and 40 years compared to the
youngest age group (<20 years). The difference in HBV
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Table 1 Distribution of blood donors according to age, marital status, education, occupation, exposure to risky procedure/
behavior, family history of HBV infection and history of HB immunization in relation to HBV markers
Total tested
(N = 3192)
HBsAg +ve
(n = 95)
Anti-HBc +ve
(n = 597)
HBV +ve markersa
(n = 692)
OR (95% CI) p-Value
Age (years)
<20 115 2 (1.7%) 10 (8.7%) 12 (10.4%) 1
20—29 2005 50 (2.5%) 265 (13.2%) 315 (15.7%) 1.60 (0.84—3.10) p = 0.127
30—39 782 33 (4.2%) 257 (32.9%) 290 (37.1%) 5.03 (2.64—9.8) p < 0.001
40 290 10 (3.4%) 65 (22.4%) 75 (25.9%) 2.99 (1.50—6.1) p = 0.001
Educationb
Higher 948 32 (3.4%) 128 (13.5%) 160 (16.9%) 1
Lower 2244 63 (2.8%) 469 (20.9%) 532 (23.7%) 1.53 (1.25—1.9) p < 0.001
Marital status
Unmarriedc 1305 47 (3.6%) 171 (13.1%) 218 (16.7%) 1
Married 1887 48 (2.5%) 426 (22.6%) 474 (25.1%) 1.67 (1.39—2.0) p < 0.001
Occupationd
Professional 997 0 128 (12.8%) 128 (12.8%) 1
Laborer 691 0 256 (37.0%) 256 (37.0%) 4.0 (3.12—5.12) p < 0.001
Military 1227 63 (5.1%) 213 (17.4%) 276 (23.5%) 1.97 (1.56—2.5) p < 0.001
Student 277 32 (11.6%) 0 32 (11.6%) 0.89 (0.57—1.36) p = 0.568
Exposure to risky procedure/behaviore
No 1455 16 (1.1%) 298 (20.5%) 314 (21.6%) 1
Yes 1737 79 (4.6%) 299 (17.2%) 378 (21.8%) 1.01 (0.85—1.20) p = 0.902
Group 1 995 29 (2.9%) 185 (18.6%) 214 (21.5%) 0.97 (0.79—1.2) p = 0.778
Group 2 297 14 (4.7%) 34 (11.4%) 48 (16.2%) 0.75 (0.53—1.04) p = 0.076
Group 3 258 21 (8.1%) 45 (17.5%) 66 (25.6%) 1.25 (0.91—1.72) p = 0.154
Group 4 187 15 (8.0%) 35 (18.7%) 50 (26.7%) 1.33 (0.92—1.90) p = 0.110
Family history of HBV infection
No 1371 47 (3.5%) 128 (9.3%) 175 (12.8%) 1
Yes 1821 48 (2.6%) 469 (25.8%) 517 (28.4%) 3.12 (2.6—3.78) p < 0.001
History of HB immunization
Yes 190 0 0 0 -
No 3002 95 (3.2%) 597 (19.9%) 692 (23.1%) - -
HBsAg, hepatitis B surface antigen; anti-HBc, anti-hepatitis B core antigen; HBV, hepatitis B virus; +ve, positive; OR, odds ratio; CI,
confidence interval.
a Positive for HBsAg, anti-HBc, or both.
b Higher education means university or higher. Lower education means less than university level (no school, primary, preparatory, or high
school).
c Unmarried includes single, divorced, or widowed.
d Professional includes doctors, engineers, teachers, lawyers, and accountants. Laborers include skilled and unskilled manual laborers.
e Exposure to risky procedure/behavior: group 1 = history of surgery, blood transfusion, dental surgery; group 2 = cauterization,
scarification, or tattooing; group 3 = high-risk sexual behavior, unprotected sex, multiple partners, anal sex, sexually transmitted diseases;
group 4 = intravenous drugs, needle or sharp injuries.markers for the age group 20—29 years in comparison to the
youngest age group (<20 years) was not significant. Of the
married subjects, 25.1% showed HBV markers compared to
16.7% of the unmarried subjects ( p < 0.05). Of the lower
educated subjects, 23.7% showed HBV markers compared to
16.9% of the higher educated ( p < 0.05). With regard to
occupation, laborers, either skilled or not, showed the high-
est percentage of HBV markers (37.0%), followed by military
personnel (23.5%). Both occupations showed significant asso-
ciation with HBV markers compared to professionals
( p < 0.05). The HBsAg marker was found in 11.6% of students
and 5.1% of military blood donors. Regarding history of
exposure to risky procedures or behaviors, all exposed groupsshowed no significant association with HBV markers
( p > 0.05). Of the subjects with a family history of HBV
infection, 28.4% showed HBV positive markers compared to
only 12.8% among those without ( p < 0.05). All study sub-
jects previously immunized for HBV in three doses were
negative for both HBsAg and anti-HBc. Of the non-immunized
subjects, 3.2% were positive for HBsAg and 19.9% were
positive for anti-HBc.
Discussion
The results of this study indicate that of the apparently
healthy male Saudi voluntary blood donors in Tabuk region,
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anti-HBc. This prevalence for HBsAg is lower than that
reported in the eastern region (6.7%) and the southwestern
region (5.4%), but higher than that reported from the central
region (1.5%) of Saudi Arabia.13,14 This prevalence is also
higher than that reported from Western countries (0.1—
0.5%), but lower than that from the Far Eastern coun-
tries.15,16 The prevalence of HBsAg among blood donors
has been found to be 3.8% in Syria, 9.8% in Yemen, 1.2% in
Egypt, and 1.2—1.7% in India.17—20 The prevalence of HBsAg
among non-vaccinated children in Tabuk was 12.7% in 1989
but eight years later (in 1997) there was a decline in this
prevalence to 0.5% among vaccinated children.21 Unfortu-
nately there are no previous studies among blood donors in
Tabuk to compare these results with.
The significant association of HBV markers with older ages
could be due to the greater number of years of potential
exposure, a lack of adult HB vaccination programs, and the
lack of awareness of HBV infection in earlier decades. Young
blood donors should be encouraged to donate blood to help
ensure a long-term increase in the blood supply without
jeopardizing safety. The differences between males and
females could not be evaluated because all subjects were
male.
An inverse relationship was observed between prevalence
of HBV markers and the socioeconomic level of the studied
population, and this result is consistent with other stu-
dies.14,22 The significant high frequency of HBV markers
among married subjects could be due to their older age.
Close to one fourth of the military subjects studied showed
HBV positive markers. This finding could be explained by
high-risk sexual behavior or the use of IV drugs, both of which
are not uncommon in military areas. Further studies are
necessary to investigate HBV infection in the military com-
munity, which represents the majority of the population
living in this area.
This study showed no significant association between HBV
markers and risky procedures/behaviors, which is not con-
sistent with other studies. This could be explained by the
effective infection control measures within healthcare facil-
ities that prevent blood-borne pathogen transmission.
Furthermore, traditional medical practices including scarifi-
cations, cauterizations, and tattooing have become infre-
quent as a result of a better utilization of free and accessible
medical care facilities.
Family history of HBV infection was found to be signifi-
cantly associated with HBVmarkers. This finding could be due
to the close contact between family members especially
children and adolescents. Shared toothbrushes, towels,
and shaving items are common among families of a lower
socioeconomic level. Al-Faleh et al. stated that HBV infection
in Saudi Arabia is acquired mainly by horizontal transmission
early in life.21 Further studies are needed to investigate
other means of HBV transmission within Saudi families.
HBV vaccination remains the cornerstone of any effective
and efficient strategy to prevent HBV infection. This study
showed that 100% of those with a history of immunization in
three doses of HBV vaccine were found to be free from HBV
markers. The finding of a very low percentage (only 6%) of HB
immunization history among study subjects corresponds with
the reality that HB vaccine was introduced to the expanded
program of immunization (EPI) in the Kingdom of Saudi Arabiastarting from October 1989 and blood donation is usually
permitted only at age 18 years and older.
In summary, the prevalence of HBV markers among blood
donors in the northwestern area of Saudi Arabia is higher
compared to the central capital Riyadh area. Socioeconomic
development, health education programs, and adult HB
immunization programs targeting high-risk groups should
be initiated. This is not a community-based study and the
subjects cannot be representative of the entire population of
the northwestern region of Saudi Arabia. Hence further
community-based studies should be encouraged to better
estimate the prevalence of HBV markers, including anti-HBs,
HBeAg, and anti-HBe, among males and females.
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